Here are relevant reports on : plasma-high-tech-ceramics-market
-
Bleeding Disorders Treatment Market by Type (Hemophilia A, Hemophilia B, vWD), Drug Class (Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antibrinolytics, Fibrin Sealant) - Global Forecast to 2021
The global bleeding disorders treatment market size is projected to grow at a CAGR of 7.9%. The major factors driving the market growth include the growing patient population base, R&D activities, and increasing focus on recombinant products by pharmaceutical companies. Emerging markets offer significant growth opportunities for the bleeding disorders treatment market.
- Published: July 2016
- Price: $ 4950
- TOC Available:
-
Electromagnetic Weapons Market by Product (Lethal Weapons, Non-lethal Weapons), Application (Homeland Security, Military), Platform (Land, Naval, Airborne), Technology (Particle Beam Weapons, Laser-induced Plasma Channel), and Region 2026
According to MarketsandMarkets, the electromagnetic weapons market is projected to reach USD 1,282 million by 2026, at a CAGR of 20.3% during the forecasting period. This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Lockheed Martin Corporation (US), Northrop Grumman Corporation (US), Thales Group (France), BAE Systems (UK), Raytheon Technologies (US), Elbit Systems (Israel) and L3Harris Technologies (US).
- Published: September 2021
- Price: $ 4950
- TOC Available:
-
Bone Growth Stimulator Market by Product (Device (External Bone Growth Stimulators), Platelet-Rich Plasma), Application (Spinal Fusion Surgeries, Oral & Maxillofacial Surgeries), End User (Hospital, Ambulatory Surgical Centers) & Region - Global Forecast to 2027
The global bone growth stimulator market in terms of revenue was estimated to be worth $1.4 billion in 2022 and is poised to reach $1.8 billion by 2027, growing at a CAGR of 5.9% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: October 2022
- Price: $ 4950
- TOC Available:
-
Hemophilia Treatment Market by Indication (Type A, Type B), Therapy (Replacement (Recombinant, Plasma Derived), Route of Administration, End User - Global Forecast to 2027
The global hemophilia treatment market is projected to reach USD ~15 billion by 2027 from USD 12 Billion in 2022, at a CAGR of 5% during the forecast period. The major players in the global hemophilia market are Bayer Healthcare (Germany), Octapharma AG (Switzerland), Novo Nordisk (Denmark), Kedrion (Italy), Pfizer Inc. (US), Biogen (US) among others.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
US Therapeutic Plasma Exchange Market by Product (Devices, Consumables), Technology (Centrifugation, Membrane Separation), Procedures & Patients (Guillain Syndrome, Multiple Sclerosis, Cryoglobulinemia), End Users & Region - Forecast to 2025
The US therapeutic plasma exchange (TPE) market, valued at $178 million in 2020, is projected to grow to $243 million by 2025, with a CAGR of 6.3%. Growth is fueled by increasing chronic disease prevalence and technological advancements, especially in continuous-flow centrifugation. However, high device costs and a shortage of skilled professionals may hinder growth.
- Published: September 2020
- Price: $ 4950
- TOC Available:
-
Biodefense Market by Technology (GHz-band Wave, Microwave Heating, RF-EMR, Cold Plasma, Gamma, UV), Product (Decontamination (Sterilization Devices, Disinfection Units), Biosensors, AI Surveillance), Application, Region - Global Forecast to 2030
The biodefense market is expected to grow from USD 0.89 billion in 2025 to USD 1.81 billion by 2030, at a compound annual growth rate (CAGR) of 15.1% during the forecast period.The Key Players STERIS (US), ASP International GmbH (a subsidiary of Fortive) (US), Ushio Inc. (Japan), Sotera Health Company (US), and Bioquell, An Ecolab Solution (UK).
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Global Forecast to 2028
The global plasma fractionation market, valued at US$27.2 billion in 2022, stood at US$29.0 billion in 2023 and is projected to advance at a resilient CAGR of 6.9% from 2025 to 2028, culminating in a forecasted valuation of US$40.4 billion by the end of the period. Market growth is driven mainly by factors such as the growing use of immunoglobulins in various therapeutic areas, strategic expansion of plasma collection centers/inventories by market players, and the growing prevalence of respiratory diseases and AATD
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Dielectric Materials Market in Electronic Displays - By Technology (LCD, LED, TFT-LCD, OLED, LCOS, Display, DLP, Plasma), Application (Conventional, 3D, Transparent, Flexible Display), & By Geography - Forecast & Analysis (2013 -2020)
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Focused Ion Beam Market by Ion Source (Ga+ Liquid Metal, Plasma, Gas Field), Application (Failure Analysis, Nanofabrication, Device Modification, Circuit Edit, Counterfeit Detection), Vertical and Region - Global Forecast to 2028
The global focused ion beam market is expected to grow from USD 1.3 billion in 2023 to USD 1.8 billion by 2028, at a compound annual growth rate (CAGR) of 7.0% during the forecast period.The Key Players Thermo Fisher Scientific Inc. (US); ZEISS International (Germany); Hitachi, Ltd. (Japan); JEOL Ltd. (Japan); TESCAN ORSAY HOLDING, a.s. (Czech Republic); Eurofins Scientific (Luxembourg); A&D Company, Limited (Japan); Veeco Instruments Inc. (US); Raith GmbH (Germany); and FOCUS GmbH (Germany).
- Published: December 2022
- Price: $ 4950
- TOC Available:
-
Blood Collection Devices Market by Product (Tubes (Plasma (EDTA, Heparin), Serum), Needles & Syringes, Blood Bags, Monitors), Method (Manual, Automated), Application (Diagnostics, Therapeutics), End User (Hospitals, Blood Banks) - Global Forecast to 2030
The global blood collection devices market, valued at US$8.61 billion in 2024, stood at US$9.13 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2024 to 2030, culminating in a forecasted valuation of US$13.02 billion by the end of the period. The growing number of accidents and trauma cases has further increased the need for rapid and reliable blood collection for diagnostics and emergency care.
- Published: November 2025
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
